Peritoneal Dialysis Market Report, Trends, Share & Insights

Peritoneal Dialysis Market Size and Trends

Global peritoneal dialysis market is estimated to be valued at USD 9.42 Bn in 2024 and is expected to reach USD 13.90 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031.

Peritoneal Dialysis Market Key Factors

Discover market dynamics shaping the industry: Request sample copy

Growing incidence of end-stage renal disease (ESRD) globally due to rising geriatric population and increase in prevalence of lifestyle diseases such as diabetes and hypertension can boost demand for peritoneal dialysis. Favorable government initiatives like Medicare and Medicaid Coverage (U.S.) and reimbursement programs for dialysis boosts the adoption of peritoneal dialysis. Furthermore, innovations in peritoneal dialysis solutions and systems by leading players can provide less painful and more convenient treatment options, which will attract more ESRD patients to opt for peritoneal dialysis.

Peritoneal Dialysis Market By Product Types

Discover high revenue pocket segments and roadmap to it: Request sample copy

Insights By Product Types - Rising prevalence of kidney diseases drives demand for peritoneal dialysis solutions

In terms of product types, peritoneal dialysis solutions segment is expected to dominate the market with 42.1% market share in 2024, due to the growing incidence of chronic kidney and end-stage renal diseases. These solutions, essential for peritoneal dialysis therapy, generate the highest revenue. Innovations in composition, such as advanced pH buffers, osmotic agents, and electrolytes, have improved their effectiveness and biocompatibility, boosting its global demand.

Insight, By Applications – Automated peritoneal dialysis (APD) segment leads owing to clinical advantages

In terms of applications, automated peritoneal dialysis (APD) segment is estimated to contribute the highest market share of 52.12% in 2024, owing to increasing adoption of automated peritoneal dialysis systems. APD offers several clinical advantages over continuous ambulatory peritoneal dialysis (CAPD) such as improved clearance of waste products, flexibility in treatment schedules and improved quality of life. With technological advancements, modern APD systems have become compact, easy to use and programmable. This has boosted their adoption significantly.

Insights By End User- Rising elderly population boosts adoption in hospitals

In terms of end user, hospitals segment is estimated to contribute the highest market share of 32.12% in 2024, owing to rising elderly population globally. Elderly are more vulnerable to develop chronic kidney diseases due to age related complications. With aging population worldwide, prevalence of kidney failure cases increases steadily. This has increased the dependency on hospitals-based dialysis procedures including peritoneal dialysis.

Regional Insights

Peritoneal Dialysis Market Regional Insights

To learn more about this report, Request sample copy

Dominating Region- North America

North America is expected to dominate the peritoneal dialysis industry with an estimated market share of 37.2% in 2024, due to factors such as strong healthcare infrastructure and widespread medical insurance coverage. Government initiatives, like Home Dialysis Incentives (U.S.) to promote home-based dialysis therapies, have also contributed to larger patient population opting for peritoneal dialysis. In February 2023, the National Kidney Foundation's Innovation Fund provided support to Relavo, a company focused on developing home dialysis solutions powered by PeritoneX technology.

Fastest-Growing Region- Asia Pacific

Asia Pacific region exhibits the fastest growth, due to growing incidences of kidney diseases such as diabetes and hypertension. Many countries like India are actively working to expand healthcare access, and this boosts adoption of peritoneal dialysis technologies. Improving IP environment also encourages local manufacturers to enter the market.

Peritoneal Dialysis Market Outlook for Key Countries

U.S.- Leading Market with Advanced Healthcare Infrastructure

The U.S. peritoneal dialysis industry is projected to witness growth significantly due to high prevalence of ESRD and well-established healthcare system. In January 2022, according to the National Kidney Foundation, approximately 785,000 Americans live with kidney failure, with a significant portion relying on dialysis treatments.

Canada- Government Support and Increasing Awareness

Canada's market is expanding due to government initiatives such as provincial reimbursement programs in Canada promoting home dialysis. In October 2024, the Canadian government announced new funding to expand home dialysis programs, with the goal of improving access for patients, particularly those in remote areas. This initiative is designed to make home-based dialysis treatments more widely available and reduce the need for patients to travel long distances for in-center care.

Japan- Technological Innovations and Aging Population

Japan's peritoneal dialysis market is characterized by advanced medical technology and rapidly aging population. In April 2020, the Ministry of Health reported that over 30% of dialysis patients in Japan uses peritoneal dialysis, reflecting the country's commitment to improving patient care.

China- Rapid Growth Driven by Healthcare Reforms

China's peritoneal dialysis industry is experiencing rapid growth due to healthcare reforms and increasing awareness of dialysis options. In March 2023, as per the National Library of Medicine, the number of patients receiving peritoneal dialysis has doubled in the past five years, highlighting the growing acceptance of this treatment in China.

India- Emerging Market with Rising Healthcare Investments

India's peritoneal dialysis industry is growing due to increased healthcare investments and awareness of kidney diseases. In August 2023, the Indian government launched initiatives like Pradhan Mantri National Dialysis Programme, to promote home dialysis, which is expected to drive market growth significantly.

Market Concentration and Competitive Landscape

Peritoneal Dialysis Market Concentration By Players

Get actionable strategies to beat competition: Request sample copy

Top Strategies Followed by Global Peritoneal Dialysis Market Players

Established Players- Leading players in the global peritoneal dialysis market focus extensively on research and development to deliver innovative products. Baxter International Inc. allocates over 10% of annual revenues to R&D and launches advanced solutions. Fresenius Medical Care undertakes collaborative R&D with top universities to create cutting-edge peritoneal dialysis systems.
Mid-Level Players- Medium sized companies focus on providing cost-effective peritoneal dialysis solutions targeting price-sensitive consumers in developing nations. B. Braun Melsungen AG offers affordable peritoneal dialysis kits and cyclers manufactured at large scale. Nipro Corp strengthens production capabilities through joint ventures in Asia and Latin America to cater to emerging low-cost markets.
Small-Scale Players- Niche players concentrate on specialized product segments left untapped by major brands. In September 2023, AWAK Technologies developed a portable peritoneal dialysis system for bed-ridden patients. Diaprost AB offers biodegradable dialysate solutions and disposables made from renewable resources. Perimed AB partners with local distributors in Europe and Asia to supply customized dialysis products and service offerings.

Emerging Startups in the Global Peritoneal Dialysis Market

Innovative Technologies- Certain startups are developing cutting-edge solutions to disrupt the market. Medtronic plc tests implantable bio-artificial kidneys created through tissue engineering. In March 2024, AiCure launched an AI platform that monitors medication adherence during peritoneal dialysis treatment through smartphones.

Sustainable Solutions- Some startups focus on sustainability in peritoneal dialysis.In September 2023, Renewville designed a point-of-care water purification system for producing hygienic dialysate using offshore wind energy. Nephrogix developed a dialysis membrane made from renewable biopolymers that can be composted after use.

Market Contribution- Startups address unmet needs through niche innovations. Dialyze Direct provides on-demand dialysis services directly to patients. In August 2023, Quanta Dialysis Technologies created a simple, portable dialysis machine ideal for home healthcare.

Peritoneal Dialysis Industry News

In August 2024, Baxter International, a global leader in healthcare solutions, and Carlyle (U.S.) finalized a definitive agreement for Carlyle to acquire Baxter's Kidney Care segment. The segment will be rebranded as Vantive, aiming to establish itself as an independent kidney care company.
In June 2023, Singapore General Hospital and AWAK Technologies, a pioneer in portable dialysis technology, announced the launch of a pre-pivotal clinical trial for an advanced version of the Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device. Recognized for its portability, the device received 'Breakthrough Device Designation' from the U.S. FDA.
In April 2023, Medtronic plc, a medical technology company, and DaVita Inc. introduced Mozarc Medical, a new independent company focused on transforming kidney health through innovative, patient-centered technology solutions
In April 2023, the U.S. FDA approved Medtronic Plc's Enlite Glucose Sensor, a device designed to enhance continuous monitoring for peritoneal dialysis (PD) treatments
In August 2022, Fresenius Medical Care AG, a global provider of dialysis products and services, acquired InterWell Health (US), a physician-led organization fostering innovation in the U.S. kidney care sector, along with Cricket Health Inc. (US), a provider of value-based kidney care leveraging a patient engagement and data platform

Key Takeaways from Analyst

Growing prevalence of end-stage renal disease (ESRD) around the world can aid the market expansion. Rising geriatric population who are more prone to chronic kidney diseases can also boost demand for peritoneal dialysis treatments. However, factors like risk of peritonitis and mechanical failures associated with peritoneal dialysis poses threat to market players.

North America currently dominates the peritoneal dialysis market and is expected to retain its leading position due to availability of advanced dialysis products and rising healthcare spending in the U.S. and Canada. Within North America, the U.S. market holds the major share. Europe is also a prominent region and growing patient awareness about peritoneal dialysis therapies will support revenue growth in this region.

Asia Pacific region, especially China and India, presents lucrative opportunities and is projected to exhibit fastest growth over the forecast period. Increasing healthcare developments and improving reimbursement scenarios in developing Asian countries boosts the adoption of peritoneal dialysis therapies. Large dialysis dependent ESRD patient pool and rising healthcare expenditure drives the market growth.

Market Report Scope

Peritoneal Dialysis Market Report Coverage

Report Coverage	Details
Base Year:	2023	Market Size in 2024:	US$ 9.42 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	5.7%	2031 Value Projection:	US$ 13.90 Bn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Product Types: Peritoneal Dialysis Solutions, Peritoneal Dialysis Catheters, Peritoneal Dialyzers, and Implantation Systems By Applications: Automated Peritoneal Dialysis (APD) and Continuous Ambulatory Peritoneal Dialysis (CAPD) By End User: Hospitals, Home Care Settings, Dialysis Centers, and Research Institutes
Companies covered:	Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic plc, B. Braun Melsungen AG, Nipro Corporation, Cook Medical, Asahi Kasei Medical Co., Ltd., Gambro (part of Fresenius), Dialife SA, Renal Solutions, Inc., Toray Industries, Inc., Nihon Kohden Corporation, Baxter Healthcare Corporation, SWS Hemodialysis Care, Inc., and Astellas Pharma Inc.
Growth Drivers:	Increasing prevalence of end-stage renal disease (ESRD) Growing adoption of home-based dialysis treatments
Restraints & Challenges:	High costs associated with peritoneal dialysis equipment and solutions Risk of infections and complications related to catheter use

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Market Dynamics

Market Driver- Increasing prevalence of end-stage renal disease (ESRD)

Rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) across the world can boost demand for peritoneal dialysis treatment. In May 2024, according to the Centers for Disease Control and Prevention (CDC) 2023 Report, chronic kidney disease (CKD) affects approximately 35.5 million people in the U.S. annually. As per the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in 2022, 25,499 individuals in the U.S. underwent kidney transplants.

Market Challenge- High costs associated with peritoneal dialysis equipment and solutions

Peritoneal dialysis requires specialized equipment and frequent dialysis solution exchanges, which leads to high treatment costs for patients. The equipment required includes a peritoneal dialysis cycler or other device to automate the fluid exchange process, specialized tubing sets and connectors, as well as sterile bags of dialysis solution that must be changed several times per day or week. The costs of these supplies and equipment pose a significant burden on healthcare systems and patients alike.

Market Opportunity- Technological advancements in dialysis equipment

Technological advancements have the potential to transform the peritoneal dialysis market and increase accessibility of treatment to more patients worldwide. New and innovative product designs allow for simpler, more user-friendly machines and systems that reduce cost of goods. Smaller, more portable cyclers have increased flexibility for home dialysis. Integrated automated systems help minimize human errors. Advances in biocompatible solutions reduce side effects like inflammation and allow for extended wear times of tubing and catheters between exchanges.

Key Stakeholders of Market

What growth in peritoneal dialysis market mean for different stakeholders?

Peritoneal dialysis industry has multiple players with varied designations and offers multiple opportunities based on their scope of operations.

Key Medical Devices Stakeholder	Opportunities Due to Peritoneal Dialysis Industry Growth
Retail Pharmacies	Offering medical devices for home use, such as blood glucose monitors and digital thermometers, expanding product offerings and customer care services.
Medical Device Manufacturers	Expansion of product lines to include innovative devices such as wearables, smart implants, and AI-driven diagnostic tools.
Healthcare Providers	Opportunities to adopt and integrate cutting-edge medical devices into patient care, improving outcomes and expanding service offerings.
Biotech Firms	Collaborating on the development of combination products, such as drug-device combinations, offering new treatment options and expanding markets.
Regulatory Affairs Specialists	Growing demand for expertise in navigating the complex regulatory landscape for medical device approvals, ensuring compliance with global standards.
Supply Chain and Logistics Providers	Managing the distribution of sensitive and high-value medical devices, including ensuring compliance with medical regulations and standards.
Medical Device Consultants	Providing strategic guidance on product development, regulatory compliance, and market entry for medical device companies.
Healthcare Training Institutions	Expanding training programs to include the use of advanced medical devices, preparing healthcare professionals for the latest technological advancements.

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Market Segmentation

Product Types Insights (Revenue, USD Bn, 2019 - 2031)
- Peritoneal Dialysis Solutions
- Peritoneal Dialysis Catheters
- Peritoneal Dialyzers
- Implantation Systems
Applications Insights (Revenue, USD Bn, 2019 - 2031)
- Automated Peritoneal Dialysis (APD)
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Home Care Settings
- Dialysis Centers
- Research Institutes
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - North Africa
  - Central Africa
Key Players Insights
- Baxter International Inc.
- Fresenius Medical Care AG & Co. KGaA
- Medtronic plc
- B. Braun Melsungen AG
- Nipro Corporation
- Cook Medical
- Asahi Kasei Medical Co., Ltd.
- Gambro (part of Fresenius)
- Dialife SA
- Renal Solutions, Inc.
- Toray Industries, Inc.
- Nihon Kohden Corporation
- Baxter Healthcare Corporation
- SWS Hemodialysis Care, Inc.
- Astellas Pharma Inc.

About Author

Ghanshyam Shrivastava - With over 20 years of experience in the management consulting and research, Ghanshyam Shrivastava serves as a Principal Consultant, bringing extensive expertise in biologics and biosimilars. His primary expertise lies in areas such as market entry and expansion strategy, competitive intelligence, and strategic transformation across diversified portfolio of various drugs used for different therapeutic category and APIs. He excels at identifying key challenges faced by clients and providing robust solutions to enhance their strategic decision-making capabilities. His comprehensive understanding of the market ensures valuable contributions to research reports and business decisions.

Ghanshyam is a sought-after speaker at industry conferences and contributes to various publications on pharma industry.

Transform your Strategy with Exclusive Trending Reports :

Neuroendocrine Tumor Treatment Market

Parkinsons Disease Therapeutics Market

Depression Therapeutics Market

Osteonecrosis Treatment Market

Hemophilia Treatment Market

Calciphylaxis Treatment Market

Frequently Asked Questions

Global peritoneal dialysis market is estimated to be valued at USD 9.42 Bn in 2024 and is expected to reach USD 13.90 Bn by 2031.

The CAGR of global peritoneal dialysis market is projected to be 5.7% from 2024 to 2031.

Increasing prevalence of end-stage renal disease (ESRD) and growing adoption of home-based dialysis treatments are the major factors driving the growth of global peritoneal dialysis market.

High costs associated with peritoneal dialysis equipment and solutions and risk of infections and complications related to catheter use are the major factors hampering the growth of global peritoneal dialysis market.

In terms of product types, peritoneal dialysis solutions segment is estimated to dominate the market in 2024.

Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic plc, B. Braun Melsungen AG, Nipro Corporation, Cook Medical, Asahi Kasei Medical Co., Ltd., Gambro (part of Fresenius), Dialife SA, Renal Solutions, Inc., Toray Industries, Inc., Nihon Kohden Corporation, Baxter Healthcare Corporation, SWS Hemodialysis Care, Inc., and Astellas Pharma Inc. are the major players.

North America is expected to lead the global peritoneal dialysis market in 2024.